Join the 200th Anniversary Celebration

Special Article

Use of Cardiac Procedures and Outcomes in Elderly Patients with Myocardial Infarction in the United States and Canada

Jack V. Tu, M.D., Ph.D., Chris L. Pashos, Ph.D., C. David Naylor, M.D., D.Phil., Erluo Chen, M.B., M.P.H., Sharon-Lise Normand, Ph.D., Joseph P. Newhouse, Ph.D., and Barbara J. McNeil, M.D., Ph.D.

N Engl J Med 1997; 336:1500-1505May 22, 1997

Abstract

Background

Acute myocardial infarction is a leading cause of morbidity and mortality in the United States and Canada. We performed a population-based study to compare the use of cardiac procedures and outcomes after acute myocardial infarction in elderly patients in the two countries.

Methods

We compared the use of invasive cardiac procedures and the mortality rates among 224,258 elderly Medicare beneficiaries in the United States and 9444 elderly patients in Ontario, Canada, each of whom had a new acute myocardial infarction in 1991.

Results

The U.S. patients were significantly more likely than the Canadian patients to undergo coronary angiography (34.9 percent vs. 6.7 percent, P< 0.001), percutaneous transluminal coronary angioplasty (11.7 percent vs. 1.5 percent, P<0.001), and coronary-artery bypass surgery (10.6 percent vs. 1.4 percent, P<0.001) during the first 30 days after the index infarction. These differences in the use of cardiac procedures narrowed but persisted through 180 days of follow-up. The 30-day mortality rates were slightly but significantly lower for the U.S. patients than for the Canadian patients (21.4 percent vs. 22.3 percent, P = 0.03). However, the one-year mortality rates were virtually identical (34.3 percent in the United States vs. 34.4 percent in Ontario, P = 0.94).

Conclusions

Short-term mortality after an acute myocardial infarction was slightly lower in the United States than in Ontario, but these differences did not persist through one year of follow-up. The strikingly higher rates of use of cardiac procedures in the United States, as compared with Canada, do not appear to result in better long-term survival rates for elderly U.S. patients with acute myocardial infarction.

Media in This Article

Figure 1Cumulative Rates of Coronary Angiography after Acute Myocardial Infarction among Elderly Patients in the United States and Ontario, 1991.
Figure 3Cumulative Mortality after Acute Myocardial Infarction among Elderly Patients in the United States and Ontario, 1991.
Article

The debate over health care reform in the United States has stimulated interest in comparing medical care in Canada and the United States, two countries with very different methods of financing health care. In particular, recent studies of acute myocardial infarction in the two countries, notably the Survival and Ventricular Enlargement (SAVE) and Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) trials, suggested that the higher rates of revascularization in the United States than in Canada in the immediate postinfarction period slightly improve the quality of life, although convincing benefits in terms of survival have not been demonstrated.1,2 These studies, however, had limited statistical power to detect clinically significant differences in mortality, because they involved relatively small numbers of patients. Furthermore, the patients were enrolled in randomized clinical trials and are therefore not representative of the full spectrum of patients with myocardial infarction in the two countries. For example, patients in Ontario, Canada, who were enrolled in the GUSTO trial were younger, had fewer coexisting illnesses, and were much more likely to undergo coronary revascularization procedures than patients in Ontario with myocardial infarction who were not enrolled in the GUSTO trial.3 Elderly patients constitute the majority of patients with myocardial infarctions in both countries but are often excluded from clinical trials of new therapeutic strategies.4,5 For these reasons, we undertook a study to compare the use of cardiac procedures and mortality in two population-based cohorts of elderly patients who had new acute myocardial infarctions in 1991 — one cohort in the United States and one in Ontario.

Methods

Sources of Data

In this study we used data on demographic characteristics, coexisting illnesses, use of procedures, and survival obtained from linked administrative and claims data bases in the two countries. The U.S. data were for calendar year 1991, whereas the Canadian data were for fiscal 1991 (April 1, 1991, through March 31, 1992).

The U.S. data base included all elderly Medicare patients with a principal diagnosis of acute myocardial infarction (codes 410.0 through 410.9 in the International Classification of Diseases, 9th Revision, Clinical Modification [ICD-9-CM]).6 The data came from the Health Care Financing Administration's Health Insurance Skeletonized Write-off data base and were linked to longitudinal data on the use of cardiac procedures in the Medicare Provider Analysis and Review and Standard Analytical Outpatient files, as described elsewhere.4

The Canadian data included all elderly patients in Ontario with a primary diagnosis of acute myocardial infarction (ICD-9-CM codes 410.0 through 410.9). These data came from the Canadian Institute for Health Information (CIHI) data base, an administrative data base containing hospital-discharge abstracts, and were linked to longitudinal data on the use of cardiac procedures in the CIHI data base and provincial vital-statistics data (from the Ontario Cancer Treatment and Research Foundation) by means of unique patient identifiers.5 Coding for cardiac procedures was based on the Canadian Classification of Diagnostic, Therapeutic, and Surgical Procedures. 7

A primary diagnosis in Ontario is the discharge diagnosis most responsible for the length of a patient's hospital stay, whereas a principal diagnosis in the United States is the discharge diagnosis responsible for the hospital admission.4,5 An audit of data on Canadian patients with a primary diagnosis of acute myocardial infarction at one hospital in Ontario has shown that this is the equivalent of a principal diagnosis of acute myocardial infarction in the United States 98 percent of the time (data not shown).

Study Cohorts

We identified comparable cohorts of elderly patients with a new myocardial infarction in the two countries using a variety of exclusion criteria.4 Patients excluded from both cohorts were those who were not representative of the elderly U.S. population (i.e., patients under the age of 65 years and patients with end-stage renal disease), patients who were likely to have been misclassified as having an acute myocardial infarction (i.e., those discharged from the hospital after a stay of less than 5 days and those transferred to another hospital within 2 days after admission when the admitting diagnosis at the receiving hospital was not a myocardial infarction), and patients with a myocardial infarction in the preceding 365 days. In the U.S. cohort, patients enrolled in health maintenance organizations were also excluded, because they were unlikely to have complete longitudinal data available. After these exclusions, a total of 224,258 patients remained in the U.S. cohort.

Two other exclusion criteria were applied to the Canadian cohort, in addition to those just described, to ensure comparability with the U.S. sample. Patients who were initially admitted for noncardiac surgery were excluded on the assumption that these patients probably had postoperative myocardial infarctions, and patients who died of a myocardial infarction outside a coronary care unit or intensive care unit on the day of admission were excluded on the assumption that they had died in the emergency room. Patients in the first category would not have been included in the U.S. cohort because their principal diagnosis would have been the type of surgery being performed, whereas patients in the second category would not have been included in the U.S. cohort because deaths in the emergency room are not considered hospital admissions for purposes of Medicare reimbursement. Patients without a valid Ontario health-card number were also excluded because we could not obtain complete follow-up data on them. After these additional exclusions, 9444 patients remained in the Canadian cohort.

Coexisting Illnesses, Use of Procedures, and Mortality

Coexisting conditions were considered to be those identified by the first seven secondary-diagnosis codes for each patient in the two data bases.8 Rates of coronary angiography, percutaneous transluminal coronary angioplasty (PTCA), and coronary-artery bypass grafting (CABG) were determined 30 days and 180 days after the index infarction. Data on outpatient coronary-angiography procedures were not uniformly available in either country. However, previous studies have shown that they constitute only a small percentage of all angiography procedures in elderly patients in the early postinfarction period9; including them in the analysis would therefore not have affected the overall conclusions substantially. The unadjusted 30-day and 1-year mortality rates among patients in the two countries were compared. Mortality rates adjusted for age and sex were also calculated for the Canadian cohort, with standardization to the age and sex distribution of the U.S. cohort.10

Characteristics of the Hospitals

The availability of facilities for catheterization and revascularization (PTCA, CABG, or both) at hospitals in both countries was determined. Hospitals were considered to provide catheterization only if they performed 5 or more cardiac catheterizations and fewer than 10 revascularization procedures annually in elderly patients with myocardial infarction, whereas hospitals were categorized as providing revascularization if they performed 10 or more revascularization procedures annually in elderly patients with myocardial infarction.11

Statistical Analysis

All continuous variables were compared with use of unpaired t-tests; categorical variables were compared with use of the chi-square statistic.12 Relative rates of use of cardiac procedures 30 days and 180 days after the index infarction in the United States as compared with Ontario were calculated, with 95 percent confidence intervals determined with use of a Taylor series expansion.10 The cumulative procedure-rate curves and cumulative mortality curves in the two cohorts were compared with use of a log-rank statistic.12 All P values are two-sided. The SAS statistical package was used for statistical analysis.13

Results

Characteristics of the Cohorts

Table 1Table 1Characteristics of Elderly Patients with Acute Myocardial Infarction in the United States and Ontario, 1991. shows the demographic characteristics and coexisting illnesses of the two cohorts of elderly patients with acute myocardial infarction in 1991. Patients in the U.S. cohort were slightly older, and this cohort contained a greater proportion of women (P<0.001 for both comparisons). The prevalence of coexisting diseases in the two cohorts was similar; the largest difference was in the prevalence of chronic pulmonary disease, which was higher in the U.S. cohort (P<0.001).

Rates of Cardiac Procedures

Rates of use of cardiac procedures are shown in Table 2Table 2Rates of Cardiac Procedures among Elderly Patients with Acute Myocardial Infarction in the United States and Ontario, 1991. and Figure 1Figure 1Cumulative Rates of Coronary Angiography after Acute Myocardial Infarction among Elderly Patients in the United States and Ontario, 1991. and Figure 2Figure 2Cumulative Rates of Percutaneous Transluminal Coronary Angioplasty (PTCA) and Coronary-Artery Bypass Grafting (CABG) after Acute Myocardial Infarction among Elderly Patients in the United States and Ontario, 1991.. Overall, the relative rate of coronary angiography in the U.S. patients as compared with the Canadian patients was 5.2 (95 percent confidence interval, 4.8 to 5.7), and the relative rate of revascularization was 7.9 (95 percent confidence interval, 7.0 to 8.9) during the first 30 days after the myocardial infarction. The rates of use of PTCA were higher than the rates of use of CABG in the early postinfarction period, whereas in the late postinfarction period the rates of use of CABG were higher than those of PTCA (Figure 2). Eighty-one percent of the U.S. patients, as compared with 48 percent of the Canadian patients, who underwent revascularization within the first 180 days after a myocardial infarction underwent the procedure within 30 days after the index infarction. Differences in rates of use of cardiac procedures persisted through 180 days of follow-up; 6 months after the index infarction, the rate of revascularization procedures in the U.S. cohort was quadruple that in the Canadian cohort. The cardiac-procedure-rate curves in the 26 weeks after the acute myocardial infarction were all significantly higher (P<0.001) for the U.S. cohort than for the Canadian cohort (Figure 1 and Figure 2).

Characteristics of the Hospitals

A higher proportion of U.S. than Canadian patients were initially admitted to hospitals that were able to perform both catheterization and revascularization procedures (34.5 percent vs. 14.0 percent, P<0.001) as well as to hospitals that performed catheterization only (22.8 percent vs. 4.1 percent, P<0.001). Overall, approximately four times as many U.S. hospitals had the capability to perform revascularization procedures, and about eight times as many were catheterization-only hospitals (Table 3Table 3Characteristics of Hospitals in the United States and Ontario, 1991.).

Outcomes after Acute Myocardial Infarction

The outcomes of the patients with acute myocardial infarction in the two cohorts are shown in Figure 3Figure 3Cumulative Mortality after Acute Myocardial Infarction among Elderly Patients in the United States and Ontario, 1991.. The cumulative mortality rates diverged relatively early and slightly favored the U.S. cohort throughout the early postinfarction period. The divergence in the mortality curves coincided with the period in which many U.S. patients were undergoing revascularization procedures (Figure 2). The unadjusted 30-day mortality rates were slightly but significantly lower in the U.S. cohort than in the Canadian cohort (21.4 percent vs. 22.3 percent, P = 0.03). However, this small difference in early mortality gradually narrowed over time, and the unadjusted one-year mortality rates were virtually identical in the U.S. and Canadian cohorts (34.3 percent and 34.4 percent, P = 0.94). The age- and sex-adjusted one-year mortality in the Canadian cohort (35.1 percent) was still not significantly different from that in the U.S. cohort after standardization to the age and sex distribution of the U.S. cohort (P = 0.14). Overall, the cumulative mortality curves for the two cohorts, shown in Figure 3, did not differ significantly (P = 0.36).

Discussion

In this study we compared the use of invasive cardiac procedures and the mortality rates for two population-based cohorts of elderly patients with acute myocardial infarction — one in the United States and one in Ontario, Canada. Ontario is Canada's largest province, home to 37 percent of its population and 21 percent of its hospitals. We found striking differences in the rates of use of invasive cardiac procedures, with the elderly U.S. patients undergoing substantially more coronary angiography and revascularization procedures, particularly during the 30 days immediately after the index infarction. We also found significant differences in the short-term outcomes of patients in the two countries, with lower 30-day mortality among the U.S. cohort, although these differences in mortality were not sustained at 1 year of follow-up. The results of our study suggest that the greater use of revascularization procedures in the United States does not improve the long-term survival rates of elderly U.S. patients with acute myocardial infarction.

The differences we found in the use of cardiac procedures are larger than those found in previous studies and could explain the small short-term difference in mortality favoring the United States. The SAVE and GUSTO comparison studies noted two- to-threefold differences in the use of revascularization procedures and similar mortality rates among nonelderly patients in the two countries enrolled in those clinical trials,1,2 whereas we found that on a population-wide basis, there were larger differences in the rates of use of cardiac procedures for elderly patients with myocardial infarction between the two countries (relative rate of procedure use in the United States as compared with Ontario, 3 to 7). Revascularization procedures were used soon after the index infarction in approximately 3 percent of the elderly Canadian patients in our study, as compared with 12 percent and 14 percent of the Canadian patients enrolled in the SAVE and GUSTO trials, respectively.1,2 Elderly patients are at significantly higher risk of dying shortly after a myocardial infarction and may be significantly more likely to benefit from the use of revascularization procedures during this period. The results of our study are consistent with the findings of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial, which showed that the aggressive use of revascularization procedures (coronary angiography in all patients within 48 hours of admission, followed by revascularization if appropriate) significantly improved the short-term survival rates among patients 65 years of age or older who presented with unstable angina or a non–Q-wave infarction.14

The absence of a sustained survival benefit over the one-year follow-up period probably reflects factors other than the differences in the use of revascularization procedures. Many medical therapies (e.g., beta-blockers and aspirin) are known to improve long-term survival after acute myocardial infarction,15 and it is possible that they were used more frequently in the Canadian cohort. The GUSTO study suggested that Canadian physicians were more likely to follow published guidelines for the medical care of nonelderly patients with myocardial infarction than their colleagues in the United States,2 although we did not have the data to test this hypothesis. The phenomenon of similar or better short-term survival rates in the United States followed by equivalent or better long-term survival rates in Canada has also been observed in other studies comparing the outcomes of elderly postsurgical patients and patients with cancer in the two countries.16-18 It has been suggested that the better short-term outcomes in the United States may be a reflection of the intensity and timeliness of U.S. hospital care, whereas the better long-term outcomes in Canada may reflect greater access to primary care, prescription drugs, and long-term care, which are universally provided to the elderly with minimal copayments, or none, under the Canadian health care system.16,17,19,20

Our results should also be interpreted in the context of other studies that have shown marked regional, national, and international variation in the use of cardiac procedures in the period after myocardial infarction.1,2,21,22 Most of these studies have focused on nonelderly patients enrolled in randomized clinical trials and have not found significant differences in mortality between areas with high rates of use and those with low rates. The number of patients in our study is several times as high and the differences in procedure rates are several times as large as in most other studies, yet we also found no substantial differences in outcome. The results of our study are likely to stimulate debate about the costs and effectiveness of the more aggressive U.S. approach to revascularization in the elderly. Although some patients' lives may have been saved by the greater use of coronary revascularization procedures in the United States and many more may have received symptomatic benefit, there may also have been other U.S. patients whose lives ended prematurely because of the high risks associated with cardiac procedures in the elderly.23

Our study has several important limitations. First, we did not have data on the quality of life of the patients in the two cohorts, and it is possible that there were important differences in functional status between the elderly U.S. and Canadian patients; such differences have been observed in other studies of nonelderly U.S. and Canadian patients with myocardial infarction.1,2 Second, one can never be sure that confounding has been completely controlled for in observational comparisons of data from administrative data bases, and it is possible that unmeasured differences in patients' characteristics or medical therapies other than those we measured may explain the short-term and long-term outcomes we found. Third, we had data on procedure rates and outcomes after a myocardial infarction only for the province of Ontario, and our results may not be generalizable to other parts of Canada.

In conclusion, we found that one-year mortality rates for elderly patients with myocardial infarction were similar in the United States and Ontario in 1991, in spite of a small short-term survival difference favoring the United States. Higher rates of use of cardiac procedures did not translate into better long-term survival rates for elderly patients in the United States. Given the many other factors known to influence short-term and long-term survival after a myocardial infarction,24,25 additional population-based studies with more detailed data on medical treatments and patients' characteristics are required before firm conclusions can be drawn about the reasons for the outcomes in our study. Although the overall results of our study appear to favor the more conservative Canadian approach to revascularization, the difference in short-term mortality favoring the United States and the question of the quality of life of elderly patients with myocardial infarction in the two countries warrant further investigation.

Supported by a grant (HS08071) from the Agency for Health Care Policy and Research. Dr. Tu is the recipient of a Health Research Personnel Development Program Fellowship (04544) and Dr. Naylor is the recipient of a Career Scientist Award (02377), both from the Ontario Ministry of Health.

The opinions and conclusions in this study are those of the authors, and no official endorsement by the Ontario Ministry of Health is intended or should be inferred.

We are indebted to Edward Guadagnoli, Ph.D., for helpful comments on an earlier version of the manuscript; to Bud Davies, Peter Gaccione, Fung-Yea Huang, Keyi Wu, and Claus Wall for assistance with statistical programming; and to the Ontario Cancer Treatment and Research Foundation for supplying vital-statistics data on the Canadian cohort.

Source Information

From the Institute for Clinical Evaluative Sciences in Ontario, North York, Ont., Canada (J.V.T., C.D.N., E.C.); the Department of Medicine, Sunnybrook Health Science Centre, University of Toronto, Toronto (J.V.T., C.D.N.); Abt Associates, Cambridge, Mass. (C.L.P.); the Departments of Biostatistics (S.-L.N.) and Health Policy and Management (J.P.N.), Harvard School of Public Health, Boston; the Kennedy School of Government, Cambridge, Mass. (J.P.N.); and the Department of Health Care Policy, Harvard Medical School, Boston (J.V.T., C.L.P., S.-L.N., J.P.N., B.J.M.).

Address reprint requests to Dr. Tu at the Institute for Clinical Evaluative Sciences, G-106, 2075 Bayview Ave., North York, ON M4N 3M5, Canada.

References

References

  1. 1

    Rouleau JL, Moye LA, Pfeffer MA, et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med 1993;328:779-784
    Full Text | Web of Science | Medline

  2. 2

    Mark DB, Naylor CD, Hlatky MA, et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med 1994;331:1130-1135
    Full Text | Web of Science | Medline

  3. 3

    Jha P, Deboer D, Sykora K, Naylor CD. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol 1996;27:1335-1342
    CrossRef | Web of Science | Medline

  4. 4

    Udvarhelyi IS, Gatsonis C, Epstein AM, Pashos CL, Newhouse JP, McNeil BJ. Acute myocardial infarction in the Medicare population: process of care and clinical outcomes. JAMA 1992;268:2530-2536
    CrossRef | Web of Science | Medline

  5. 5

    Naylor CD, Chen E. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: the Ontario experience, 1981 to 1991. J Am Coll Cardiol 1994;24:1431-1438
    CrossRef | Web of Science | Medline

  6. 6

    The international classification of diseases, 9th rev., clinical modification: ICD-9-CM. Ann Arbor, Mich.: Commission on Professional and Hospital Activities, 1992.

  7. 7

    Canadian classification of diagnostic, therapeutic, and surgical procedures. Ottawa, Ont.: Minister of Industry, Science, and Technology, 1993.

  8. 8

    Normand SLT, Morris CN, Fung KS, McNeil BJ, Epstein AM. Development and validation of a claims based index for adjusting for risk of mortality: the case of acute myocardial infarction. J Clin Epidemiol 1995;48:229-243
    CrossRef | Web of Science | Medline

  9. 9

    Pashos CL, Newhouse JP, McNeil BJ. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990. JAMA 1993;270:1832-1836
    CrossRef | Web of Science | Medline

  10. 10

    Hennekens CH, Buring JE. Epidemiology in medicine. Boston: Little, Brown, 1987.

  11. 11

    McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA 1994;272:859-866
    CrossRef | Web of Science | Medline

  12. 12

    Rosner BA. Fundamentals of biostatistics. 4th ed. Belmont, Calif.: Duxbury Press, 1995.

  13. 13

    SAS release 6.11. Cary, N.C.: SAS Institute, 1996.

  14. 14

    The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB Trial. Circulation 1994;89:1545-1556
    Web of Science | Medline

  15. 15

    Hennekens CH, Albert CM, Godfried SL, Gaziano JM, Buring JE. Adjunctive drug therapy of acute myocardial infarction -- evidence from clinical trials. N Engl J Med 1996;335:1660-1667
    Full Text | Web of Science | Medline

  16. 16

    Roos LL, Fisher ES, Sharp SM, Newhouse JP, Anderson G, Bubolz TA. Postsurgical mortality in Manitoba and New England. JAMA 1990;263:2453-2458
    CrossRef | Web of Science | Medline

  17. 17

    Roos LL, Fisher ES, Brazauskas R, Sharp SM, Shapiro E. Health and surgical outcomes in Canada and the United States. Health Aff (Millwood) 1992;11:56-72
    CrossRef | Web of Science | Medline

  18. 18

    General Accounting Office. Cancer survival: an international comparison of outcomes. Washington, D.C.: Government Printing Office, 1994:1-45. (Publication no. GAO/PEMD-94-5.)

  19. 19

    Barer ML, Hertzman C, Miller R, Pascali MV. On being old and sick: the burden of health care for the elderly in Canada and the United States. J Health Polit Policy Law 1992;17:763-782
    CrossRef | Web of Science | Medline

  20. 20

    Gordon M. Geriatrics and the Canadian health care system: perspective of an Ontario geriatrician. J Am Geriatr Soc 1992;40:421-424
    Web of Science | Medline

  21. 21

    Pilote L, Califf RM, Sapp S, et al. Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med 1995;333:565-572
    Full Text | Web of Science | Medline

  22. 22

    Van de Werf F, Topol EJ, Lee KL, et al. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries: results from the GUSTO trial. JAMA 1995;273:1586-1591
    CrossRef | Web of Science | Medline

  23. 23

    Peterson ED, Jollis JG, Bebchuk JD, et al. Changes in mortality after myocardial revascularization in the elderly: the national Medicare experience. Ann Intern Med 1994;121:919-927
    Web of Science | Medline

  24. 24

    Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation 1995;91:1659-1668
    Web of Science | Medline

  25. 25

    Rouleau JL, Talajic M, Sussex B, et al. Myocardial infarction patients in the 1990s -- their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol 1996;27:1119-1127
    CrossRef | Web of Science | Medline

Citing Articles (81)

Citing Articles

  1. 1

    Zhenyu Wang, Yanzhong He, Xindi Yu, Wei Fu, Wei Wang, Huimin Huang. (2012) Rapid vascularization of tissue-engineered vascular grafts in vivo by endothelial cells in co-culture with smooth muscle cells. Journal of Materials Science: Materials in Medicine
    CrossRef

  2. 2

    Joseph J Doyle. (2011) Returns to Local-Area Health Care Spending: Evidence from Health Shocks to Patients Far From Home. American Economic Journal: Applied Economics 3:3, 221-243
    CrossRef

  3. 3

    Wendy Tsang, David A. Alter, Harindra C. Wijeysundera, Tony Zhang, Dennis T. Ko. (2011) The Impact of Cardiovascular Disease Prevalence on Women's Enrollment in Landmark Randomized Cardiovascular Trials: A Systematic Review. Journal of General Internal Medicine
    CrossRef

  4. 4

    David M. Cutler. (2011) Where Are the Health Care Entrepreneurs? The Failure of Organizational Innovation in Health Care. Innovation Policy and the Economy 11:1, 1-28
    CrossRef

  5. 5

    Michael E. Chernew, Joseph P. Newhouse. 2011. Health Care Spending Growth. , 1-43.
    CrossRef

  6. 6

    Fiona M Clement, Braden J Manns, Brenda Brownell, Peter D Faris, Michelle M Graham, Karin Humphries, Michael Love, Merril L Knudtson, William A Ghali. (2011) A multi-region assessment of population rates of cardiac catheterization and yield of high-risk coronary artery disease. BMC Health Services Research 11:1, 323
    CrossRef

  7. 7

    Xuefeng Bu, Yulan Yan, Zhijian Zhang, Xiaochu Gu, Mubing Wang, Aihua Gong, Xianglan Sun, Yanhong Cui, Yanjun Zeng. (2010) Properties of Extracellular Matrix-Like Scaffolds for the Growth and Differentiation of Endothelial Progenitor Cells. Journal of Surgical Research 164:1, 50-57
    CrossRef

  8. 8

    Alexis Pozen, David M. Cutler. (2010) Medical Spending Differences in the United States and Canada: The Role of Prices, Procedures, and Administrative Expenses. Inquiry 47:2, 124-134
    CrossRef

  9. 9

    Liqiong Gui, Akihito Muto, Stephen A. Chan, Christopher K. Breuer, Laura E. Niklason. (2009) Development of Decellularized Human Umbilical Arteries as Small-Diameter Vascular Grafts. Tissue Engineering Part A 15:9, 2665-2676
    CrossRef

  10. 10

    Jian-Ming Lü, Xinwen Wang, Christian Marin-Muller, Hao Wang, Peter H Lin, Qizhi Yao, Changyi Chen. (2009) Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Review of Molecular Diagnostics 9:4, 325-341
    CrossRef

  11. 11

    Masoor Kamalesh, Usha Subramanian, Anahita Ariana, George J. Eckert, Stephen Sawada. (2008) Paradoxical lower postmyocardial infarction mortality among veteran women – does a sex bias exist in the Veterans Affairs medical system?. Canadian Journal of Cardiology 24:9, 691-695
    CrossRef

  12. 12

    Thérèse A. Stukel, Michael J. Schull, Astrid Guttmann, David A. Alter, Ping Li, Marian J. Vermeulen, Douglas G. Manuel, Merrick Zwarenstein. (2008) Health Impact of Hospital Restrictions on Seriously Ill Hospitalized Patients. Medical Care 46:9, 991-997
    CrossRef

  13. 13

    P. Zorlutuna, N. Hasirci, V. Hasirci. (2008) Nanopatterned collagen tubes for vascular tissue engineering. Journal of Tissue Engineering and Regenerative Medicine 2:6, 373-377
    CrossRef

  14. 14

    Peter C. Austin, Lawrence J. Brunner. (2008) Optimal Bayesian probability levels for hospital report cards. Health Services and Outcomes Research Methodology 8:2, 80-97
    CrossRef

  15. 15

    T. Aper, A. Haverich, O.E. Teebken. (2008) Der Traum vom idealen Bypassmaterial in der Gefäßchirurgie. Gefässchirurgie 13:2, 87-98
    CrossRef

  16. 16

    Saejeong Kim, Horst von Recum. (2008) Endothelial Stem Cells and Precursors for Tissue Engineering: Cell Source, Differentiation, Selection, and Application. Tissue Engineering Part B: Reviews 14:1, 133-147
    CrossRef

  17. 17

    Dennis T. Ko, Yongfei Wang, David A. Alter, Jeptha P. Curtis, Saif S. Rathore, Therese A. Stukel, Fredrick A. Masoudi, Joseph S. Ross, JoAnne M. Foody, Harlan M. Krumholz. (2008) Regional Variation in Cardiac Catheterization Appropriateness and Baseline Risk After Acute Myocardial Infarction. Journal of the American College of Cardiology 51:7, 716-723
    CrossRef

  18. 18

    Peter A. Kavsak, Dennis T. Ko, Alice M. Newman, Glenn E. Palomaki, Viliam Lustig, Andrew R. MacRae, Allan S. Jaffe. (2008) “Upstream markers” provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes. Clinica Chimica Acta 387:1-2, 133-138
    CrossRef

  19. 19

    Richard F. Heller, Rachel L. O'Connell, Catherine D'Este, Lynette L.-Y. Lim, Peter J. Fletcher. (2008) DIFFERENCES IN CARDIAC PROCEDURES AMONG PATIENTS IN METROPOLITAN AND NON-METROPOLITAN HOSPITALS IN NEW SOUTH WALES AFTER ACUTE MYOCARDIAL INFARCTION AND ANGINA. Australian Journal of Rural Health 8:6, 310
    CrossRef

  20. 20

    Mohammad I. Zia, Shaun G. Goodman, Eric D. Peterson, Jyotsna Mulgund, Anita Y. Chen, Anatoly Langer, Mary Tan, E. Magnus Ohman, W. Brian Gibler, Charles V. Pollack, Matthew T. Roe. (2007) Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: An international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II. Canadian Journal of Cardiology 23:13, 1073-1079
    CrossRef

  21. 21

    Farooq A. Chaudhry, Ehtasham A. Qureshi, Siu-Sun Yao, Sripal Bangalore. (2007) Risk Stratification and Prognosis in Octogenarians Undergoing Stress Echocardiographic Study. Echocardiography 24:8, 851-859
    CrossRef

  22. 22

    David J. Becker. (2007) Do Hospitals Provide Lower Quality Care on Weekends?. Health Services Research 42:4, 1589-1612
    CrossRef

  23. 23

    Barry A. Franklin. (2007) Lessons Learned From the COURAGE Trial: Generalizability, Limitations, and Implications. Preventive Cardiology 10:3, 117-120
    CrossRef

  24. 24

    David Mooney, Yu Ching Yung. 2007. Engineering Smooth Muscle. , 24-1-24-14.
    CrossRef

  25. 25

    Xinwen Wang, Peter Lin, Qizhi Yao, Changyi Chen. (2007) Development of Small-Diameter Vascular Grafts. World Journal of Surgery 31:4, 682-689
    CrossRef

  26. 26

    T. Aper, A. Schmidt, M. Duchrow, H.-P. Bruch. (2007) Autologous Blood Vessels Engineered from Peripheral Blood Sample. European Journal of Vascular and Endovascular Surgery 33:1, 33-39
    CrossRef

  27. 27

    Barry A. Franklin. (2006) Coronary revascularization and medical management of coronary artery disease: changing paradigms and perceptions. European Journal of Cardiovascular Prevention & Rehabilitation 13:5, 669-673
    CrossRef

  28. 28

    Dennis T. Ko, David N. Juurlink, Muhammad M. Mamdani, John J. You, Julie T. Wang, Linda R. Donovan, Jack V. Tu. (2006) Appropriateness of Spironolactone Prescribing in Heart Failure Patients: A Population-Based Study. Journal of Cardiac Failure 12:3, 205-210
    CrossRef

  29. 29

    S.J. Kim, D.E. Schaubel, S.S.A. Fenton, A.B. Leichtman, F.K. Port. (2006) Mortality After Kidney Transplantation: A Comparison Between the United States and Canada. American Journal of Transplantation 6:1, 109-114
    CrossRef

  30. 30

    Glenn N. Levine, A. Michael Lincoff, James J. Ferguson, Kenneth W. Mahaffey, Shaun G. Goodman, Christopher P. Cannon, Pierre Theroux, Keith A.A. Fox. (2005) Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade. Catheterization and Cardiovascular Interventions 66:2, 149-157
    CrossRef

  31. 31

    STEPHEN J. KUNITZ, IRENA PESIS-KATZ. (2005) Mortality of White Americans, African Americans, and Canadians: The Causes and Consequences for Health of Welfare State Institutions and Policies. The Milbank Quarterly 83:1, 5-39
    CrossRef

  32. 32

    Seung-Woo Cho, Sang Hyun Lim, Il-Kwon Kim, Yoo Sun Hong, Sang-Soo Kim, Kyung Jong Yoo, Hyun-Young Park, Yangsoo Jang, Byung Chul Chang, Cha Yong Choi, Ki-Chul Hwang, Byung-Soo Kim. (2005) Small-Diameter Blood Vessels Engineered With Bone Marrow???Derived Cells. Annals of Surgery 241:3, 506-515
    CrossRef

  33. 33

    Douglas S. Lee, Linda Donovan, Peter C. Austin, Yanyan Gong, Peter P. Liu, Jean L. Rouleau, Jack V. Tu. (2005) Comparison of Coding of Heart Failure and Comorbidities in Administrative and Clinical Data for Use in Outcomes Research. Medical Care 43:2, 182-188
    CrossRef

  34. 34

    Daniel Simonet. (2005) Patient satisfaction under managed care. International Journal of Health Care Quality Assurance 18:6, 424-440
    CrossRef

  35. 35

    Dale M. Needham, Susan E. Bronskill, William J. Sibbald, Peter J. Pronovost, Andreas Laupacis. (2004) Mechanical ventilation in Ontario, 1992–2000: Incidence, survival, and hospital bed utilization of noncardiac surgery adult patients*. Critical Care Medicine 32:7, 1504-1509
    CrossRef

  36. 36

    Paula A. Rochon, Kathy Sykora, Susan E. Bronskill, Muhammad Mamdani, Geoffrey M. Anderson, Jerry H. Gurwitz, Sudeep Gill, Jack V. Tu, Andreas Laupacis. (2004) Use of Angiotensin-converting Enzyme Inhibitor Therapy and Dose-related Outcomes in Older Adults with New Heart Failure in the Community. Journal of General Internal Medicine 19:6, 676-683
    CrossRef

  37. 37

    Erwan L’Her, Françoise Duquesne, Emmanuelle Girou, Xavier Donin Rosiere, Philippe Le Conte, Serge Renault, Jean-Paul Allamy, Jean-Michel Boles. (2004) Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Medicine 30:5, 882-888
    CrossRef

  38. 38

    T. Niemann, R. Labouriau, H. Toft Sorensen, N. Thorsgaard, T. Toftegaard Nielsen. (2004) Prognostic impact of different regional referral practices for interventional investigation and coronary treatment after exercise testing: a population-based 5-year follow-up study. Journal of Internal Medicine 255:4, 478-485
    CrossRef

  39. 39

    David A Halon, Salim Adawi, Idit Dobrecky-Mery, Basil S Lewis. (2004) Importance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients. Journal of the American College of Cardiology 43:3, 346-352
    CrossRef

  40. 40

    Ami Schattner, Robert H. Fletcher. (2004) Pearls and Pitfalls in Patient Care: Need to Revive Traditional Clinical Values. The American Journal of the Medical Sciences 327:2, 79-85
    CrossRef

  41. 41

    Vikas Prabhakar, Mark W. Grinstaff, Javier Alarcon, Chris Knors, Amy K. Solan, Laura E. Niklason. (2003) Engineering porcine arteries: Effects of scaffold modification. Journal of Biomedical Materials Research 67A:1, 303-311
    CrossRef

  42. 42

    Steven P. Higgins, Amy K. Solan, Laura E. Niklason. (2003) Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation. Journal of Biomedical Materials Research 67A:1, 295-302
    CrossRef

  43. 43

    A. Schattner. (2003) The essence of patient care. Journal of Internal Medicine 254:1, 1-4
    CrossRef

  44. 44

    Louise Pilote, Olga Saynina, Frederic Lavoie, Mark Mcclellan. (2003) Cardiac Procedure Use and Outcomes in Elderly Patients with Acute Myocardial Infarction in the United States and Quebec, Canada, 1988 to 1994. Medical Care 41:7, 813-822
    CrossRef

  45. 45

    Petersen, Laura A., Normand, Sharon-Lise T., Leape, Lucian L., McNeil, Barbara J., . (2003) Regionalization and the Underuse of Angiography in the Veterans Affairs Health Care System as Compared with a Fee-for-Service System. New England Journal of Medicine 348:22, 2209-2217
    Full Text

  46. 46

    Masashi Nomi, Anthony Atala, Paolo De Coppi, Shay Soker. (2002) Principals of neovascularization for tissue engineering. Molecular Aspects of Medicine 23:6, 463-483
    CrossRef

  47. 47

    BM Hegde. (2002) Doctor's dilemma. Medical Journal Armed Forces India 58:4, 289-292
    CrossRef

  48. 48

    David M Cutler. (2002) Equality, Efficiency, and Market Fundamentals: The Dynamics of International Medical-Care Reform. Journal of Economic Literature 40:3, 881-906
    CrossRef

  49. 49

    Rajendra H Mehta, Douglas A Criger, Christopher B Granger, Karen K Pieper, Robert M Califf, Eric J Topol, Eric R Bates. (2002) Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability. Journal of the American College of Cardiology 40:6, 1034-1040
    CrossRef

  50. 50

    Vladimir Džavík, Jean-L.uçien Rouleau. (2002) Should all patients with an acute myocardial infarction present to a hospital with revascularization capabilities?. Journal of the American College of Cardiology 40:6, 1041-1043
    CrossRef

  51. 51

    Pushkal P. Garg, Mary Beth Landrum, Sharon-Lise T. Normand, John Z. Ayanian, Paul J. Hauptman, Thomas J. Ryan, Barbara J. McNeil, Edward Guadagnoli. (2002) Understanding Individual and Small Area Variation in the Underuse of Coronary Angiography Following Acute Myocardial Infarction. Medical Care 40:7, 614-626
    CrossRef

  52. 52

    Richard A. Deyo. (2002) C ASCADE E FFECTS OF M EDICAL T ECHNOLOGY. Annual Review of Public Health 23:1, 23-44
    CrossRef

  53. 53

    Hon-Kan Yip, Chiung-Jen Wu, Hsueh-Wen Chang, Chi-Ling Hang, Chih-Yuan Fang, Yuan-Kai Hsieh, Cheng-Hsu Yang, Chien-Jen Chen, Kuo-Ho Yeh, Sarah Chua, Morgan Fu, Mien-Cheng Chen. (2002) Comparison of Primary Angioplasty and Conservative Treatment on Short- and Long-term Outcome in Octogenarian or Older Patients with Acute Myocardial Infarction.. Japanese Heart Journal 43:5, 463-474
    CrossRef

  54. 54

    K. M. Detre, R. Holubkov. (2002) Coronary Revascularization on Balance: Robert L. Frye Lecture. Mayo Clinic Proceedings 77:1, 72-82
    CrossRef

  55. 55

    E. F. Philbin, P. A. McCullough, T. G. DiSalvo, G. W. Dec, P. L. Jenkins, W. D. Weaver. (2001) Underuse of invasive procedures among Medicaid patients with acute myocardial infarction. American Journal of Public Health 91:7, 1082-1088
    CrossRef

  56. 56

    (2001) Appropriateness of Coronary Angiography after Myocardial Infarction among Medicare Beneficiaries. New England Journal of Medicine 344:10, 774-775
    Full Text

  57. 57

    Jack V Tu, Peter C Austin, Randy Walld, Leslie Roos, Jean Agras, Kathryn M McDonald. (2001) Development and validation of the ontario acute myocardial infarction mortality prediction rules. Journal of the American College of Cardiology 37:4, 992-997
    CrossRef

  58. 58

    Richard F. Heller, Rachel L. O'Connell, Catherine D'Este, Lynette L.-Y. Lim, Peter J. Fletcher. (2000) Differences in Cardiac Procedures Among Patients in Metropolitan and Non-Metropolitan Hospitals in New South Wales After Acute Myocardial Infarction and Angina. Australian Journal of Rural Health 8:6, 310-317
    CrossRef

  59. 59

    Ira S. Nash. (2000) Dynamic Assessment in Disease Management. Disease Management and Health Outcomes 8:3, 139-146
    CrossRef

  60. 60

    Anthony Ratcliffe. (2000) Tissue engineering of vascular grafts. Matrix Biology 19:4, 353-357
    CrossRef

  61. 61

    Charles L. Baird, Scott E. Crater. (2000) Medical management of significant coronary angiographic stenoses: Outcome of 60 patients observed for 433 patient years. Clinical Cardiology 23:8, 591-594
    CrossRef

  62. 62

    Philip S Wang, Alexander Walker, Ming Tsuang, E.John Orav, Raisa Levin, Jerry Avorn. (2000) Strategies for improving comorbidity measures based on Medicare and Medicaid claims data. Journal of Clinical Epidemiology 53:6, 571-578
    CrossRef

  63. 63

    Uwe E Reinhardt. (2000) Health Care for the Aging Baby Boom: Lessons from Abroad. Journal of Economic Perspectives 14:2, 71-84
    CrossRef

  64. 64

    David M Cutler. (2000) Walking the Tightrope on Medicare Reform. Journal of Economic Perspectives 14:2, 45-56
    CrossRef

  65. 65

    Alfred Sommer. (1999) Health, medicine, and ophthalmology: facing the facts and paying the piper LVI Edward Jackson memorial lecture. American Journal of Ophthalmology 128:6, 673-679
    CrossRef

  66. 66

    Alter, David A., Naylor, C. David, Austin, Peter, Tu, Jack V., . (1999) Effects of Socioeconomic Status on Access to Invasive Cardiac Procedures and on Mortality after Acute Myocardial Infarction. New England Journal of Medicine 341:18, 1359-1367
    Full Text

  67. 67

    Wayne B Batchelor, Eric D Peterson, Daniel B Mark, J.David Knight, Christopher B Granger, Paul W Armstrong, Robert M Califf. (1999) A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications. Journal of the American College of Cardiology 34:1, 12-19
    CrossRef

  68. 68

    Shmuel Gottlieb, Valentina Boyko, David Harpaz, Hanoch Hod, Miriam Cohen, Lori Mandelzweig, Zahi Khoury, Shlomo Stern, Solomon Behar. (1999) Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction. Journal of the American College of Cardiology 34:1, 70-82
    CrossRef

  69. 69

    Patrick J Scanlon, David P Faxon, Anne-Marie Audet, Blase Carabello, Gregory J Dehmer, Kim A Eagle, Ronald D Legako, Donald F Leon, John A Murray, Steven E Nissen, Carl J Pepine, Rita M Watson, James L Ritchie, Raymond J Gibbons, Melvin D Cheitlin, Kim A Eagle, Timothy J Gardner, Arthur Garson, Richard O Russell, Thomas J Ryan, Sidney C Smith. (1999) ACC/AHA guidelines for coronary angiography. Journal of the American College of Cardiology 33:6, 1756-1824
    CrossRef

  70. 70

    Robert M. Kaplan. (1999) Shared medical decision-making: A new paradigm for behavioral medicine—1997 presidential address. Annals of Behavioral Medicine 21:1, 3-11
    CrossRef

  71. 71

    Lee A. Fleisher, Srinivas Mantha, Michael F. Roizen. (1998) Medical Technology Assessment. Anesthesia & Analgesia 87:6, 1271-1282
    CrossRef

  72. 72

    Sidney C. Smith Jr.. (1998) What Is Happening in the Real World in Lipid Therapy and Is It Appropriate? The Need for a Paradigm Shift. Value in Health 1:4, 204-207
    CrossRef

  73. 73

    Teresa S.M Tsang, William K Freeman, Marion E Barnes, Guy S Reeder, Douglas L Packer, James B Seward. (1998) Rescue echocardiographically guided pericardiocentesis for cardiac perforation complicating catheter-based procedures. Journal of the American College of Cardiology 32:5, 1345-1350
    CrossRef

  74. 74

    Abel E Moreyra, Alan C Wilson, Patrice M Gregory, John B Kostis. (1998) Coronary angioplasty during hospitalization for acute myocardial infarction is associated with higher 5-year survival. Disease Management and Clinical Outcomes 1:5, 175-180
    CrossRef

  75. 75

    Joseph De Gregorio, Yoshio Kobayashi, Remo Albiero, Bernhard Reimers, Carlo Di Mario, Leo Finci, Antonio Colombo. (1998) Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up. Journal of the American College of Cardiology 32:3, 577-583
    CrossRef

  76. 76

    Salim Yusuf, Marcus Flather, Janice Pogue, David Hunt, John Varigos, Leopoldo Piegas, Alvaro Avezum, Jeffrey Anderson, Matyas Keltai, Andrzej Budaj, Keith Fox, Leszek Ceremuzynski. (1998) Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. The Lancet 352:9127, 507-514
    CrossRef

  77. 77

    Kathleen Hartford, Leslie L. Roos, Randy Walld. (1998) Regional Variation in Angiography, Coronary Artery Bypass Surgery, and Percutaneous Transluminal Coronary Angioplasty in Manitoba, 1987 to 1992. Medical Care 36:7, 1022-1032
    CrossRef

  78. 78

    Charlyn Black, Noralou P. Roos. (1998) Administrative Data. Medical Care 36:1, 3-5
    CrossRef

  79. 79

    C. Richard Conti. (1998) Can physicians practice cost-effective medicine?. Clinical Cardiology 21:1, 2-3
    CrossRef

  80. 80

    (1997) Use of Cardiac Procedures in the United States and Canada. New England Journal of Medicine 337:14, 1008-1009
    Full Text

  81. 81

    Krumholz, Harlan M., . (1997) Cardiac Procedures, Outcomes, and Accountability. New England Journal of Medicine 336:21, 1522-1523
    Full Text

Letters